China Tobacco International (HK) Co (6055) AI Stock Analysis

• Market Cap: HK$25.23B
• Dividend Yield: 1.44%
• Average Volume (3M): 2.08M
• Price to Earnings (P/E): 25.1
• Beta (1Y): 0.80
• Revenue Growth: 14.77%
• EPS Growth: 16.77%
• Country: HK
• Employees: 307
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Tobacco
• EPS (TTM): 0.40
• Shares Outstanding: 691,680,000
• 10 Day Avg. Volume: 3,036,355
• 30 Day Avg. Volume: 2,080,103
• PEG Ratio: 0.47
• Price to Book (P/B): 5.47
• Price to Sales (P/S): 1.26
• P/FCF Ratio: 26.91
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: HK$46.24
• Price Target Upside: 29.38% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 5
• EPS Forecast (FY): 1.57
• Revenue Forecast (FY): HK$15.45B

• Rating: 72 Outperform
• Price Target: HK$45.00 ▲(25.91% Upside)
• Action: Upgraded Date: 01/22/26
• Date: Action: Upgraded 01/22/26

The score is driven primarily by strong financial performance (revenue and margin improvements plus strong ROE), partially offset by weak cash flow trends (lower operating cash flow and zero free cash flow in 2024). Technicals show an uptrend but with overbought signals (RSI ~75), and valuation looks demanding (P/E ~27.5) with only a modest dividend yield.

Positive Factors

Revenue and Margin Improvement

Consistent double-digit revenue growth and rising gross and net margins reflect durable demand and improved cost control in the company's trading and export operations. Over the medium term, this supports reinvestment, scalable margins from higher throughput, and resilience of core trading economics.

High Return on Equity

A 28%+ ROE signals efficient use of shareholder capital in the trading/distribution model. Given authorized roles within the China National Tobacco ecosystem, this suggests structural profitability advantages and effective capital allocation that can sustain returns if access and volume persist.

Stable Leverage Profile

Stable debt-to-equity around 1.0 provides predictable financing capacity for a working-capital intensive trading business. This leverage level, combined with system access to procurement and distribution channels, supports medium-term funding of inventory and export volumes without extreme balance-sheet strain.

Negative Factors

Weak Cash Generation

A sharp decline in operating cash flow and zero free cash flow undermine the company's ability to internally fund inventory, capex, and distributions. For a trading business with heavy working capital needs, persistent weak cash conversion forces reliance on external financing and limits strategic flexibility.

Lower Equity Ratio

A lower equity ratio increases financial vulnerability and reduces shock absorption capacity. For a trade-centric exporter dependent on receivables and inventory, increased reliance on liabilities raises refinancing and liquidity risk, potentially constraining growth or increasing funding costs under stress.

Modest Operating Margins

Relatively modest EBIT/EBITDA margins indicate limited operating efficiency headroom. In a business sensitive to tobacco leaf prices, logistics and FX, small margin contractions can materially hit profitability and cash flow, restricting the company's ability to absorb cost shocks or invest in growth initiatives.

China Tobacco International (HK) Co Business Overview & Revenue Model

Company Description

China Tobacco International (HK) Company Limited engages in the trade of tobacco products. The company operates through Tobacco Leaf Products Export Business, Tobacco Leaf Products Import Business, Cigarettes Export Business, and New Tobacco Products Export Business segments. The Tobacco Leaf Products Export Business segment procures and exports tobacco leaf products to cigarette manufacturers and authorized purchasing agents of cigarette manufacturers. The Tobacco Leaf Products Import Business segment imports tobacco leaf products to mainland China. The Cigarettes Export Business segment exports cigarettes to duty-free outlets and cigarettes wholesalers. The New Tobacco Products Export Business segment exports new tobacco products to retailers, cigarettes wholesalers, and independent third parties. It operates in the People's Republic of China, Indonesia, Hong Kong, the Philippines, Vietnam, Singapore, Barzil, and internationally. The company was incorporated in 2004 and is headquartered in Kowloon, Hong Kong. China Tobacco International (HK) Company Limited is a subsidiary of China Tobacco International Group Limited.

How the Company Makes Money

China Tobacco International (HK) Co generates revenue primarily through the sale of its tobacco products in international markets. The company's revenue model is largely driven by the import and export of cigarettes, which are sold to various distributors and retailers worldwide. Key revenue streams include direct sales to foreign markets, partnerships with local distributors, and licensing agreements that allow other companies to produce and sell its brands. Additionally, the company benefits from economies of scale due to its affiliation with the China National Tobacco Corporation, which provides it with access to a vast tobacco supply and resources for efficient production and distribution. Market demand for tobacco products, pricing strategies, and regulatory factors in different regions also significantly influence the company's earnings.

China Tobacco International (HK) Co Financial Statement Overview

Summary

Strong revenue growth (+10.4% from 2023 to 2024) and improved profitability (gross margin 10.54%, net margin 6.53%) support a solid score. Balance sheet leverage appears stable and ROE is strong (28.41%), but the lower equity ratio (30.61%) adds some risk. The main drag is cash generation, with operating cash flow dropping significantly and free cash flow at zero in 2024.

Income Statement

The company has demonstrated strong revenue growth, with a 10.4% increase from 2023 to 2024. Gross profit margin improved to 10.54% in 2024, indicating better cost management. Net profit margin rose to 6.53%, showing enhanced profitability. However, EBIT and EBITDA margins were slightly lower at 10.25% and 9.66% respectively, suggesting room for operational efficiency improvement.

Balance Sheet

The company's debt-to-equity ratio increased from 1.00 in 2023 to 0.99 in 2024, indicating a stable leverage position. Return on equity (ROE) improved to 28.41%, reflecting effective use of equity. The equity ratio decreased to 30.61%, highlighting increased reliance on liabilities. Overall, the balance sheet is strong but could benefit from a higher equity ratio.

Cash Flow

The cash flow statement shows mixed results, with a significant drop in operating cash flow from 2023 to 2024. Free cash flow growth rate is unavailable due to zero free cash flow in 2024, raising concerns about cash generation capabilities. The company needs to enhance its cash flow management to support growth and operational needs.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	14.69B	13.07B	11.84B	8.32B	8.06B	3.48B
Gross Profit	1.36B	1.38B	1.09B	793.57M	400.56M	130.72M
EBITDA	1.24B	1.26B	1.08B	750.92M	738.91M	112.75M
Net Income	916.75M	853.74M	598.77M	374.90M	702.83M	106.12M
Balance Sheet
Total Assets	10.00B	9.82B	6.74B	6.37B	4.77B	3.80B
Cash, Cash Equivalents and Short-Term Investments	3.98B	2.86B	2.33B	1.79B	1.66B	1.63B
Total Debt	2.55B	2.98B	2.49B	2.11B	1.31B	25.53M
Total Liabilities	6.30B	6.63B	4.05B	4.13B	2.78B	2.06B
Stockholders Equity	3.50B	3.01B	2.49B	2.02B	1.76B	1.75B
Cash Flow
Free Cash Flow	2.00B	610.44M	501.77M	-390.07M	30.13M	31.94M
Operating Cash Flow	2.01B	629.44M	517.91M	-383.80M	30.97M	42.83M
Investing Cash Flow	-653.77M	-459.99M	-1.70B	11.21M	12.34M	65.72M
Financing Cash Flow	-753.82M	-164.01M	-27.05M	512.66M	-43.33M	-156.81M

China Tobacco International (HK) Co Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 35.74
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:6055, the sentiment is Negative. The current price of 35.74 is below the 20-day moving average (MA) of 40.55, below the 50-day MA of 39.27, and below the 200-day MA of 37.26, indicating a neutral trend. The MACD of -0.90 indicates Positive momentum. The RSI at 38.95 is Neutral, neither overbought nor oversold. The STOCH value of 25.70 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:6055.

China Tobacco International (HK) Co Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
6055	72 Outperform	HK$25.23B	25.06	27.43%	1.44%	14.77%	16.77%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
6969	58 Neutral	HK$56.25B	62.96	4.76%	2.03%	15.05%	-30.92%

China Tobacco International (HK) Co Corporate Events

China Tobacco International (HK) Strengthens Board Governance With New Lead INED and Committee Appointment

China Tobacco International (HK) Company Limited has designated existing independent non-executive director (INED) Chow Siu Lui as lead independent non-executive director, effective 31 December 2025, to strengthen corporate governance. Chow, who already chairs the audit and remuneration committees and sits on the nomination and strategic development committees, will serve as a key communication channel between INEDs, the board and shareholders, without assuming additional executive or managerial responsibilities. The firm has also appointed INED He Junhua as a member of the nomination committee from the same date, ensuring the committee includes a director of a different gender. These board changes are being implemented to align with the amended Corporate Governance Code that took effect in July 2025 and are aimed at enhancing board effectiveness, diversity and overall governance standards at the company.

The most recent analyst rating on (HK:6055) stock is a Hold with a HK$36.00 price target. To see the full list of analyst forecasts on China Tobacco International (HK) Co stock, see the HK:6055 Stock Forecast page.

China Tobacco International (HK) Details Board and Committee Structure

China Tobacco International (HK) Company Limited has announced the current composition of its board of directors and the allocation of roles across its five key board committees. The board is chaired by non-executive director Shao Yan and includes four executive directors and four independent non-executive directors, reflecting a governance structure with a significant independent component. The company has detailed the membership of its Audit, Nomination, Remuneration, Connected Transactions Control and Strategic Development Committees, designating independent director Chow Siu Lui as lead independent director and chair of both the Audit and Remuneration Committees, while Shao Yan chairs the Nomination and Strategic Development Committees and Wang Xinhua leads the Connected Transactions Control Committee. The announcement underlines the group’s emphasis on board oversight, risk management and strategic planning, which is closely watched by investors in light of regulatory scrutiny and governance expectations for Hong Kong-listed state-linked enterprises.

The most recent analyst rating on (HK:6055) stock is a Hold with a HK$36.00 price target. To see the full list of analyst forecasts on China Tobacco International (HK) Co stock, see the HK:6055 Stock Forecast page.

China Tobacco International (HK) Tightens Governance With Revised Nomination Committee Mandate

China Tobacco International (HK) Company Limited has formalised updated terms of reference for its Nomination Committee, specifying that the committee will be composed of at least three directors, with a majority being independent non-executive directors and at least one member of a different gender, and chaired by either the board chairman or an independent non-executive director. The committee is tasked with overseeing board structure and composition, identifying and recommending director candidates, assessing the independence of non-executive directors, guiding succession planning for key leadership roles, supporting regular board performance evaluations, and reviewing its own effectiveness annually, underscoring the company’s efforts to strengthen corporate governance and board oversight for stakeholders.

The most recent analyst rating on (HK:6055) stock is a Hold with a HK$36.00 price target. To see the full list of analyst forecasts on China Tobacco International (HK) Co stock, see the HK:6055 Stock Forecast page.

China Tobacco International Extends Key Tobacco Leaf Supply and Service Deals With Alliance One

China Tobacco International (HK) Company Limited has renewed a series of framework agreements governing the sale and purchase of tobacco leaves and related services with Alliance One International and its Brazilian subsidiary, Alliance One Brazil, both of which are connected persons at the subsidiary level via their 49% interest in CBT. The parties signed new 2025 extension agreements to prolong the existing sales and purchase frameworks for three years from 1 January 2026 to 31 December 2028 and to formalise additional terms for procuring services related to the processing and production of tobacco leaf products, while keeping other key terms and pricing policies unchanged. As these arrangements involve connected parties under Hong Kong listing rules, the renewed agreements are classified as continuing connected transactions, underscoring the importance of Alliance One Group as a strategic partner in the group’s tobacco leaf supply chain and the company’s ongoing reliance on this relationship for stable sourcing and processing capacity.

The most recent analyst rating on (HK:6055) stock is a Hold with a HK$36.00 price target. To see the full list of analyst forecasts on China Tobacco International (HK) Co stock, see the HK:6055 Stock Forecast page.

China Tobacco International Expands Global Cigar Distribution

China Tobacco International (HK) Company Limited has entered into an exclusive distribution agreement with China Tobacco Anhui for the global market distribution of ‘Wangguan’ cigars, excluding Mainland China. This agreement extends the company’s distribution scope beyond its previous duty-free markets, marking a significant step in establishing a global sales platform for Chinese cigars. The move is expected to enhance the company’s international influence and competitiveness in the cigar market.

The most recent analyst rating on (HK:6055) stock is a Hold with a HK$40.00 price target. To see the full list of analyst forecasts on China Tobacco International (HK) Co stock, see the HK:6055 Stock Forecast page.